Involvement of natural killer T cells in C57BL/6 mouse model of collagen-induced arthritis

Journal of Microbiology, Immunology and Infection

Volumn 36, Issue 1, 2003, Pages 15-20

  Wang, Chrong Reen ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Collagen induced arthritis; Natural killer T cells; Rheumatoid arthrit1is

Indexed keywords

COLLAGEN TYPE 2; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL INFILTRATION; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; LYMPH NODE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; RHEUMATOID ARTHRITIS; SPLEEN; SYNOVIUM; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; COLLAGEN; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL;

EID: 0037353661     PISSN: 02532662     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 2000;12:676-83.
2. + T cells: a new family of T cells. Immunol Today 1996;17:71-6.
3. + T cells. Curr Opin Immunol 1995;7:367-74.
4. Bendelac A, Rivera MN, Park SH, Roark JH. Mouse CD1specific NK1 T cells: development, specificity, and function. Ann Rev Immunol 1997;15:535-62.
5. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Ann Rev Immunol 1993;11:613-35.
6. - single positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor Vβ family. Proc Natl Acad Sci USA 1992;89:6506-10.
7. Taniguchi M, Koeski H, Tokuhisa T, Masuda K, Sato H, Kondo E, Kawano T, Cui J, Perkes A, Koyasu S, Maturino Y. Essential requirement of an invariant Vα14 T cell antigen receptor expression in the development of natural killer T cells. Proc Natl Acad Sci USA 1996;93:11025-8.
8. Gumperz JE, Brenner MB. CD1-specific T cells in microbial immunity. Curr Opin Immunol 2001;13:471-8.
9. Mendiratte SK, Martin WD, Hong S, Boestanu A, Joyce S, Van Kaer L. CD1d mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 1997;6:469-77.
10. Joyce S, Woods AS, Yewdell JW, Bennink JR, DeSilva AD, Boesteanu A, Balk SP, Cotter RJ, Bruttiewicz RR. Natural ligand of mouse CD1d: cellular glycosylphosphatidylinositol. Science 1998;279:1541-4.
11. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, kondo E, koseki H, Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NK T cells by glycosylceramides. Science 1997;278:1626-9.
12. pos T cells promptly produce interleukin 4 in response to in vivo challenge with antiCD3. J Exp Med 1994;179:1285-95.
13. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J Immunol 1997;159:2240-9.
14. +-like thymocytes in the NOD mouse. Eur J Immunol 1996;26:2989-98.
15. + T cells that promptly produce interleukin 4. Proc Natl Acad Sci USA 1995;92:11931-4.
16. + NK T cells associated with disease development in autoimmune-prone mice. J Immunol 1996;156:4035-40.
17. Lehuen A, Lantz O, Beaudoin L, Camaud C, Bendelac A, Bach JF, Monteiro RC. Overexpression of natural killer T cells protects Vα14-Jα281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998;188:1831-9.
18. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural difference. J Rheumatol 1994;21:302-6.
19. Panayi GS. T-cell-dependent pathways in rheumatoid arthritis. Curr Opin Rheumatol 1997;9:236-40.
20. Chiocchia G, Boissier MC, Fournier C. Therapy against murine collagen-induced arthritis with T cell receptor Vβ-specific antibodies. Eur J Immunol 1991;21:2899-905.
21. Mauri C, Williams RO, Walmsley M. Relationship between Th1 and Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 1996;26:1511-8.
22. b) mice: new insights into an important disease model of rheumatoid arthritis. Eur J Immunol 2000;30:1568-75.
23. Plater-Zyberk C, Taylor PC, Blaylock MG, Maini RN. Anti-CD5 therapy decreases severity of established disease in collagen type II-induced arthritis in DBA/1 mice. Clin Exp Immunol 1994;98:442-7.
24. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 1995;95:2868-76.
25. Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998;76:275-88.
26. Satoh M, Seki S, Hashimoto W, Ogasawara K, Kobayashi T, Kamagai K, Matsuno S, Takeda K. Cytotoxic γδ or αβ T cells with a natural killer cell maker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2. J Immunol 1996;157:3886-99.
27. Schmidt RE, Murray C, Daley JF, Schlosmann SF, Ritz J. A subset of natural killer cells in peripheral blood displays a mature T-cell phenotype. J Exp Med 1986;164:351-6.
28. Porcelli S, Yockey CE, Brenner MB, Balk SP. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8-αβ T cells demonstrates preferential use of several Vβ genes and invariant TCR α chain. J Exp Med 1993;178:1-16.
29. - T cells. J Exp Med 1997;186:109-20.
30. Nieda M, Nicol A, Juji T, Koezuka Y, Kikuchi A, Takahashi T, Nakamura H, Furukawa H, Yabe Y, Ishikawa Y, Tadokoro K. Activation of human Vα24 NK T cells by α-galactosylceramide in a CD1d-restricted and Vα24 TCR-mediated manner. Human Immunol 1999;60:10-9.
31. + double-negative T cells in rheumatoid synovium. Rheumatol 1999;38:186-8.
32. Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, VanKaer L. Cutting edge: activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 1999;163:2373-7.